BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37309673)

  • 41. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
    Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
    BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Olfactomedin 4 deletion induces colon adenocarcinoma in Apc
    Liu W; Li H; Hong SH; Piszczek GP; Chen W; Rodgers GP
    Oncogene; 2016 Oct; 35(40):5237-5247. PubMed ID: 26973250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt-β-catenin-mediated intestinal tumor growth and regeneration.
    Phesse TJ; Buchert M; Stuart E; Flanagan DJ; Faux M; Afshar-Sterle S; Walker F; Zhang HH; Nowell CJ; Jorissen R; Tan CW; Hirokawa Y; Eissmann MF; Poh AR; Malaterre J; Pearson HB; Kirsch DG; Provero P; Poli V; Ramsay RG; Sieber O; Burgess AW; Huszar D; Vincan E; Ernst M
    Sci Signal; 2014 Sep; 7(345):ra92. PubMed ID: 25270258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted suppression of beta-catenin blocks intestinal adenoma formation in APC Min mice.
    Foley PJ; Scheri RP; Smolock CJ; Pippin J; Green DW; Drebin JA
    J Gastrointest Surg; 2008 Aug; 12(8):1452-8. PubMed ID: 18521697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
    Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y
    Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas.
    Souazé F; Viardot-Foucault V; Roullet N; Toy-Miou-Leong M; Gompel A; Bruyneel E; Comperat E; Faux MC; Mareel M; Rostène W; Fléjou JF; Gespach C; Forgez P
    Carcinogenesis; 2006 Apr; 27(4):708-16. PubMed ID: 16299383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers.
    Luke JJ; Bao R; Sweis RF; Spranger S; Gajewski TF
    Clin Cancer Res; 2019 May; 25(10):3074-3083. PubMed ID: 30635339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.
    Freeman TJ; Smith JJ; Chen X; Washington MK; Roland JT; Means AL; Eschrich SA; Yeatman TJ; Deane NG; Beauchamp RD
    Gastroenterology; 2012 Mar; 142(3):562-571.e2. PubMed ID: 22115830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RNA helicase p68 deploys β-catenin in regulating RelA/p65 gene expression: implications in colon cancer.
    Khare V; Tabassum S; Chatterjee U; Chatterjee S; Ghosh MK
    J Exp Clin Cancer Res; 2019 Jul; 38(1):330. PubMed ID: 31351496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Vγ4/butyrophilin conspiracy: novel role of intraepithelial γδ T cells in chronic inflammatory bowel disease.
    Kabelitz D
    Signal Transduct Target Ther; 2023 Nov; 8(1):433. PubMed ID: 37980330
    [No Abstract]   [Full Text] [Related]  

  • 51. TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma.
    Yakou MH; Ghilas S; Tran K; Liao Y; Afshar-Sterle S; Kumari A; Schmid K; Dijkstra C; Inguanti C; Ostrouska S; Wilcox J; Smith M; Parathan P; Allam A; Xue HH; Belz GT; Mariadason JM; Behren A; Drummond GR; Ruscher R; Williams DS; Pal B; Shi W; Ernst M; Raghu D; Mielke LA
    Sci Immunol; 2023 Oct; 8(88):eadf2163. PubMed ID: 37801516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in circulating γδ T cells in patients with primary colon cancer and relation with prognostic factors.
    Andreu-Ballester JC; Galindo-Regal L; Hidalgo-Coloma J; Cuéllar C; García-Ballesteros C; Hurtado C; Uribe N; Del Carmen Martín M; Jiménez AI; López-Chuliá F; Llombart-Cussac A
    PLoS One; 2020; 15(12):e0243545. PubMed ID: 33326443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. γδ T cell dichotomy with opposing cytotoxic and wound healing functions in human solid tumors.
    Harmon C; Zaborowski A; Moore H; St Louis P; Slattery K; Duquette D; Scanlan J; Kane H; Kunkemoeller B; McIntyre CL; Scannail AN; Moran B; Anderson AC; Winter D; Brennan D; Brehm MA; Lynch L
    Nat Cancer; 2023 Aug; 4(8):1122-1137. PubMed ID: 37474835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A butyrophilin family member critically inhibits T cell activation.
    Yamazaki T; Goya I; Graf D; Craig S; Martin-Orozco N; Dong C
    J Immunol; 2010 Nov; 185(10):5907-14. PubMed ID: 20944003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SPDEF Induces Quiescence of Colorectal Cancer Cells by Changing the Transcriptional Targets of β-catenin.
    Lo YH; Noah TK; Chen MS; Zou W; Borras E; Vilar E; Shroyer NF
    Gastroenterology; 2017 Jul; 153(1):205-218.e8. PubMed ID: 28390865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma.
    Huge N; Sandbothe M; Schröder AK; Stalke A; Eilers M; Schäffer V; Schlegelberger B; Illig T; Vajen B; Skawran B
    Hepatol Int; 2020 May; 14(3):373-384. PubMed ID: 31440992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation.
    Reyes RM; Deng Y; Zhang D; Ji N; Mukherjee N; Wheeler K; Gupta HB; Padron AS; Kancharla A; Zhang C; Garcia M; Kornepati AVR; Boyman O; Conejo-Garcia JR; Svatek RS; Curiel TJ
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33849925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A fetal wave of human type 3 effector γδ cells with restricted TCR diversity persists into adulthood.
    Tan L; Fichtner AS; Bruni E; Odak I; Sandrock I; Bubke A; Borchers A; Schultze-Florey C; Koenecke C; Förster R; Jarek M; von Kaisenberg C; Schulz A; Chu X; Zhang B; Li Y; Panzer U; Krebs CF; Ravens S; Prinz I
    Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33893173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isolation, Characterization, and Culture of Intestinal Intraepithelial Lymphocytes.
    James OJ; Vandereyken M; Swamy M
    Methods Mol Biol; 2020; 2121():141-152. PubMed ID: 32147793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.